Show simple item record

A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro

dc.contributor.authorTavakkol, Amiren_US
dc.contributor.authorZouboulis, Christos C.en_US
dc.contributor.authorDuell, Elizabeth A.en_US
dc.contributor.authorVoorhees, John J.en_US
dc.date.accessioned2006-09-08T21:14:01Z
dc.date.available2006-09-08T21:14:01Z
dc.date.issued1994-06en_US
dc.identifier.citationTavakkol, Amir; Zouboulis, Christos C.; Duell, Elizabeth A.; Voorhees, John J.; (1994). "A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro ." Molecular Biology Reports 20(2): 75-83. <http://hdl.handle.net/2027.42/43250>en_US
dc.identifier.issn0301-4851en_US
dc.identifier.issn1573-4978en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/43250
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7715611&dopt=citationen_US
dc.description.abstractA retinoic acid (RA) inducible skin-specific gene transcript (RIS-1) was isolated by differential hybridization screening of a RA-treated human skin cDNA library. The library was constructed from pooled RNA derived from normal adult human skin treated with all trans -RA for 4 h (n=6) and 12 h (n=6) in vivo . RIS-1 cDNA corresponded to a 0.6 kb transcript that was barely detectable in normal adult human skin but was significantly induced by 8 h in RA-treated compared to vehicle-treated skin (range 1.1–3.6 fold). Prolonged RA treatment for up to 24 h further increased relative RIS-1 mRNA levels by 1.3–5.5 fold. HPLC analysis of the RA content of 0.1% RA-treated skin in vivo revealed significant levels at 6 h (18.8–120.6 ng RA/g wet weight tissue; approximately 240 nM), immediately preceding the time point at which the increased RIS-1 mRNA level was first seen. This concentration of RA also induced the mRNA levels for cellular RA binding protein II (1.6–19 fold), a marker of RA activity in human skin. RIS-1 mRNA was detected by Northern and dot blotting only in normal skin but not in any other normal human tissues examined, indicating a tissue-specific pattern of gene expression. RIS-1 transcripts were detected at very low levels in untreated cultured human epidermal keratinocytes, while no expression was seen in dermal fibroblasts and melanocytes, the other major cell types in skin. Southern analysis of human and mouse DNA indicated the existence of evolutionarily conserved sequences for RIS-1 between these two species. The polypeptide sequence derived from the partial RIS-1 cDNA was found to be identical to the calcium binding domain found in ‘psoriasin’, a gene whose expression appears to be increased in the skin of psoriasis patients.en_US
dc.format.extent1391417 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springer Science+Business Mediaen_US
dc.subject.otherLife Sciencesen_US
dc.subject.otherAnimal Biochemistryen_US
dc.subject.otherAnimal Anatomy / Morphology / Histologyen_US
dc.subject.otherRetinoic Aciden_US
dc.subject.otherSkinen_US
dc.subject.otherDifferential Hybridizationen_US
dc.subject.otherCloningen_US
dc.subject.otherKeratinocytesen_US
dc.subject.otherGene Expressionen_US
dc.titleA retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitroen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbsecondlevelEcology and Evolutionary Biologyen_US
dc.subject.hlbsecondlevelNatural Resources and Environmenten_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, 48109, Ann Arbor, MI, USA; Preclinical Dermatology Research, Hoffmann-La Roche Inc., Rm. 710, Bldg. 86, 340 Kingsland Street, 07110-1199, Nutley, NJ, USAen_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, 48109, Ann Arbor, MI, USA; Preclinical Dermatology Research, Hoffmann-La Roche Inc., Rm. 710, Bldg. 86, 340 Kingsland Street, 07110-1199, Nutley, NJ, USAen_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, 48109, Ann Arbor, MI, USA; Preclinical Dermatology Research, Hoffmann-La Roche Inc., Rm. 710, Bldg. 86, 340 Kingsland Street, 07110-1199, Nutley, NJ, USAen_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, 48109, Ann Arbor, MI, USA; Preclinical Dermatology Research, Hoffmann-La Roche Inc., Rm. 710, Bldg. 86, 340 Kingsland Street, 07110-1199, Nutley, NJ, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid7715611en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/43250/1/11033_2004_Article_BF00996356.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00996356en_US
dc.identifier.sourceMolecular Biology Reportsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.